Companies
Versalis
Bio-elastomers — Bio-butadiene.
- Country
- Italy
Coverage
| CN | EU | US | |
|---|---|---|---|
| polymers-materials | ✓ | ✓ | ✓ |
Regulatorsepa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Versalis provided over $20 million in funding to Genomatica for the bio-butadiene joint venture | report.eni.com · versalis.eni.com · eni.com |
| Production site | Ravenna, Italy (specialty polymers and elastomers production) | argusmedia.com · rubbernews.com |
| Certification | ISCC PLUS Certificate for the Ravenna site | versalis.eni.com |
| Headcount | 5,708 (as of 2013-12-31) | report.eni.com |
| Revenue | Intermediates revenue of €2,709 million (as of 2013) | report.eni.com |
Independent sources: argusmedia.com · eni.com · report.eni.com · rubbernews.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic latex | polymers-materials | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.